HELION BIOTECH ApS: Financial statements 2024
CVR: 31758106
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
HELION BIOTECH ApS (CVR 31758106) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -45,045 and a net result of DKK -43,895 compared with DKK -48,167 the year before. Equity in the 2024 report amounted to DKK 149,533. The solvency ratio was 74.1%.
- Gross Profit
- DKK -45,045
- Profit/Loss
- DKK -43,895
- Equity
- DKK 149,533
- Total Assets
- DKK 201,710
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -45K | -44K | 150K | - |
| 2023 | - | 26K | -48K | 193K | - |
| 2022 | - | 33K | 22K | 242K | - |
| 2021 | - | 55K | 11K | 220K | - |
| 2020 | - | 34K | 28K | 209K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
HELION BIOTECH ApS has published its annual report for 2023. Gross profit came to DKK 25,698, and the net result was DKK -48,167.
About HELION BIOTECH ApS
HELION BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Steffen Thiel (chair), Jens Christian Jensenius and Per Bo Pedersen Fischer. The company is owned by HELION HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -27,115 and a net result of DKK -32,019 compared with DKK -43,895 the year before. Equity in the 2025 report amounted to DKK 117,514.